Palivizumab Injection Shortage
Last Updated: August 13, 2025
Status: Discontinued
To Be Discontinued:
- Synagis, Injection, 100 mg/1 mL (Swedish Orphan Biovitrum AB)
- Synagis, Injection, 50 mg/.5 mL (Swedish Orphan Biovitrum AB)
Synagis, Injection, 100 mg/1 mL (Swedish Orphan Biovitrum AB)
NDC Code: 66658-231-01Status: To Be Discontinued
Date of update: August 13, 2025
Update type: New
Related Information: Discontinuation of the manufacture of the drug
Therapeutic category: Antiviral
Date discontinued: August 13, 2025
Initial posting date: August 13, 2025
Contact info: 866-773-5274
Synagis, Injection, 50 mg/.5 mL (Swedish Orphan Biovitrum AB)
NDC Code: 66658-230-01Status: To Be Discontinued
Date of update: August 13, 2025
Update type: New
Related Information: Discontinuation of the manufacture of the drug
Therapeutic category: Antiviral
Date discontinued: August 13, 2025
Initial posting date: August 13, 2025
Contact info: 866-773-5274
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.